【CCM 2879 交流专区】马化工

icy97

马化工73%药业送股东

2017年8月3日
（吉隆坡2日讯）马化工（CCM，2879，主板工业产品股）宣布私下配售、出售地皮等企业活动，包括将间接持有马化工药业（CCMDBIO，7148，主板消费产品股）的73.37%股权分发给股东。

马化工向交易所报备，将私下配售最多的10%缴足股本，预计筹得6760万令吉，主要用来偿还银行贷款和作为营运资本。

同时，也建议以1.9亿令吉脱售三片地皮，所得将用来偿还银行贷款。

马化工建议，将间接持有马化工药业的73.37%股权，分发给马化工的股东。

值得注意的是，马化工是通过马化工营销私人有限公司，持有马化工药业的73.37%股权。

由于马化工营销欠下马化工4亿7410万令吉，因此转移股权的成本，相等于是每股2.32令吉。

马化工表示，如此一来，合格的股东及其他投资者，可以分开评估马化工和马化工药业的财务表现及前景等。【e南洋】

Type	Announcement
Subject	MULTIPLE PROPOSALS
Description	CHEMICAL COMPANY OF MALAYSIA BERHAD (CCMB OR COMPANY)(I)        PROPOSED PLACEMENT; (II)        PROPOSED DISPOSAL OF SHAH ALAM LAND;(III)        PROPOSED DISTRIBUTION AND CAPITAL REDUCTION; AND(IV)        PROPOSED SHARE CONSOLIDATION (COLLECTIVELY REFERRED TO AS PROPOSALS)
On behalf of the Board of Directors of CCMB, Maybank Investment Bank Berhad wishes to announce that the Company intends to undertake the Proposals. Please refer to the attachment for further details on the Proposals. This announcement is dated 2 August 2017.

http://www.bursamalaysia.com/market/listed-companies/company-announcements/5505489

Attachments CCMB - Proposals vF.pdf

Type	Announcement
Subject	MULTIPLE PROPOSALS
Description	CHEMICAL COMPANY OF MALAYSIA BERHAD (CCMB OR COMPANY)(I)        PROPOSED PLACEMENT; (II)        PROPOSED DISPOSAL OF SHAH ALAM LAND;(III)        PROPOSED DISTRIBUTION AND CAPITAL REDUCTION; AND(IV)        PROPOSED SHARE CONSOLIDATION (COLLECTIVELY REFERRED TO AS PROPOSALS)
(Reference is made to the Company’s announcement dated 2 August 2017 in relation to the Proposals ("Announcement"). Unless otherwise stated, all abbreviations and definitions used herein shall have the same meanings as those used in the Announcement.) On behalf of CCMB, Maybank IB wishes to clarify the following statement set out in Section 2.1.3 of the Announcement: 'The Disposal Consideration represents a discount of approximately 2.2% to the latest audited NBV of the Shah Alam Land as at 31 December 2016' The statement should be read as follows instead: 'The Disposal Consideration represents a premium of approximately 2.2% to the latest audited NBV of the Shah Alam Land (including the buildings thereon) as at 31 December 2016' This Announcement is dated 2 August 2017.

icy97

母公司精简业务 子公司无拘无束
马化工分拆药业缔双赢

2017年8月3日
（吉隆坡3日讯）马化工（CCM，2879，主板工业产品股）集团董事经理伦纳德阿立夫认为，分拆马化工药业（CCMDBIO，7148，主板消费产品股）对两者均有好处；对母公司来说，可以精简业务、优化成本及赚幅，而对被分拆的子公司而言，则是可以无拘束地发展。

马化工是在周三闭市后，向马交所报备，建议一连串企业活动，包括配售和卖地筹资、将马化工药业股票分发给马化工股东、及整合股票。

伦纳德阿立夫今天在记者会上解释，之所以决定把股票分发给股东，而不是将其脱售，是因为知道很多股东都是通过持有马化工，间接享有马化工药业的优势。

“在这企业活动，股东不会是输家，因为马化工的股东除了持有原本的马化工股票，还能‘获赠’马化工药业的股票。”

他说，马化工药业的前景明朗，且早前也宣布了数项拓展计划，但碍于母公司的负债而导致借贷能力受限，因此决定分拆马化工药业，让后者能在无拘束下更好地发展。

冀减债至1亿

马化工目前的债务达4.4亿令吉，其中有4亿令吉属于长期贷款，另4000万令吉是营运资本的资金。

伦纳德阿立夫冀望通过配售和卖地，将债务从4.4亿令吉，削减至接近1亿令吉。

目前，该公司所支付的利息成本达2100万令吉。一旦偿还贷款后，利息成本将只剩原本的四分之一。

他表示，分拆马化工药业并不是一朝一夕的决定，而是该公司从2015年起，就计划要做的事情。

回顾2015年，马化工把旗下制药业务都整合在单一个体，以达到综合资源，进而提升产品素质和营运效率等目的。

去年，马化工脱售拉低集团表现的肥料业务，整顿损益表；今年，则是整顿资产负债表，因此决定削资，并把马化工药业的股份分发给股东。

完成分拆后，马化工将专注于化学制品及聚合物业务，而马化工药业则能专注发展制药业务。

针对上述建议，该公司放眼在10月至12月间召开股东特别大会，并瞄准年杪完成分拆活动。



优化成本和赚幅

失去了制药业务，马化工的企业规模也随之缩小，但伦纳德阿立夫并不担心竞争力问题。

目前，马化工是我国第三大化学制品业者，排在国油石化（PCHEM ，5183，主板工业产品股）和乐天大腾化学（LCTITAN，5284，主板工业产品股）之后。

“我们的业务其实并不小，化学制品在我国的市占率有35%，聚合物的市占率也有一定规模。”

虽然净利也会减少，但他认为，分拆业务并不会影响马化工的业务，反而能够优化成本及赚幅，并看好上半年的表现可以延续至下半年。

聚合物业务标青

此外，分拆制药业务后，化学制品业务将成为营业额的主要贡献者，但从获利能力来看，则是聚合物产品的表现更标青。

去年，该公司已经投资5000万令吉资本开销，拓展化学制品业务，因此，今年只拨出约1000万令吉的资本开销。至于聚合物业务，马化工则会专注于消除瓶颈，提升产能。

国投药业持股逼近50%

也是马化工药业总执行长的伦纳德阿立夫说，将马化工药业的股票分发给马化工的股东后，大股东国民投资机构在马化工药业的持股率，将从原本的4%，增至约50%。

“如果国民投资机构参与配售计划的话，持股率会更高。而散落在市场的股票至少会有40%。”

无论如何，股票分发的比例仍有待确定。【e南洋】

icy97

Type	Announcement
Subject	MULTIPLE PROPOSALS
Description	CHEMICAL COMPANY OF MALAYSIA BERHAD ("CCMB" OR "COMPANY")(I)        PROPOSED PLACEMENT; (II)        PROPOSED DISPOSAL OF SHAH ALAM LAND;(III)        PROPOSED DISTRIBUTION AND CAPITAL REDUCTION; AND(IV)        PROPOSED SHARE CONSOLIDATION (COLLECTIVELY REFERRED TO AS PROPOSALS)
(Reference is made to the Company’s announcements dated 2 August 2017 in relation to the Proposals ("Announcement"). Unless otherwise stated, all abbreviations and definitions used herein shall have the same meanings as those used in the Announcement) On behalf of CCMB, Maybank IB wishes to make amended announcement and further clarification on the Proposals. Please refer to the attachment for further details.

http://www.bursamalaysia.com/market/listed-companies/company-announcements/5506949

Attachments CCMB 170804 - Amended Announcement further clarification final.pdf

icy97

Type	Announcement
Subject	OTHERS
Description	CLARIFICATION OF ARTICLE ENTITLED CCM CHIEF DEFENDS DEMERGER EXERCISE PUBLISHED IN THE STARBIZ ON FRIDAY, 4 AUGUST 2017
Reference is made to an Article entitled ‘CCM chief defends demerger exercise’ appearing on page 2 of the STARBIZ section of the The Star newspaper published on Friday, 4 August 2017. The Company wishes to deny the above statements allegedly made by Mr Leonard Ariff bin Abdul Shatar, Group Managing Director of Chemical Company of Malaysia Berhad, in so far as they relate to the alleged expected gross proceeds from the sale of the said non-core assets. Please refer to attachment below for further details.

http://www.bursamalaysia.com/market/listed-companies/company-announcements/5507649

Attachments CCMB Announcement - Clarify StarBiz (rev draft040817) (2).docx

icy97

小股东患得患失/万年船

2017年8月6日

小股东大权利

马化工派股下下策

反观最新的马化工（CCM）建议派发马化工药业（CCMDBIO），是这类企业活动的下下之策。

马化工宣布一系列企业活动，其中一项是把马化工药业派给股东，比例约5派2（或1派0.4）。

马化工和合顺同属国民投资机构（PNB）的子公司，再加上森那美（SIME），看来国民投资机构近来的活动目标，是以这种将股回退股东的方式为主。

以马化工药业的2.10令吉股价来说，这个股息达84仙，比较马化工的1.60令吉，周息率高达50%。

不过，美中不足的是，马化工之后将进行3合1整合股票，意思是股东的股权不变，股额少了三分之二。

大凡小股东的直接反应，是有股息拿，不管是现金也好、股票也好，不要拒绝，但是如果伤害到自己的股额，那就另当别论。

拿了马化工药业的股票（折合84仙），但是自个儿的股额少了67%，股价要站在多少钱才打成平手？（1.60-0.84）x3 = 2.40令吉。

印象中马化工处于在高位是7至8年前的事，看来马化工的股东和达洋企业的股东一样，患得患失，输少当赢。【e南洋】

icy97

Type	Announcement
Subject	MULTIPLE PROPOSALS
Description	CHEMICAL COMPANY OF MALAYSIA BERHAD ("CCMB" OR "COMPANY")(I)        PROPOSED PLACEMENT; (II)        PROPOSED DISPOSAL OF SHAH ALAM LAND;(III)        PROPOSED DISTRIBUTION AND CAPITAL REDUCTION; AND(IV)        PROPOSED SHARE CONSOLIDATION (COLLECTIVELY REFERRED TO AS PROPOSALS)
(Reference is made to the Company’s announcements dated 2 August 2017 and 4 August 2017 in relation to the Proposals ("Announcement"). Unless otherwise stated, all abbreviations and definitions used herein shall have the same meanings as those used in the Announcement) On behalf of CCMB, Maybank IB wishes to announce certain updates in relation to the Proposals. Please refer to the attachment for further details.

http://www.bursamalaysia.com/market/listed-companies/company-announcements/5512797

Attachments CCMB 170811 - Announcement revised proposal structure and submission.pdf

icy97

SUMMARY OF KEY FINANCIAL INFORMATION 30 Jun 2017

		INDIVIDUAL PERIOD		CUMULATIVE PERIOD
		CURRENT YEAR QUARTER	PRECEDING YEAR CORRESPONDING QUARTER	CURRENT YEAR TO DATE	PRECEDING YEAR CORRESPONDING PERIOD
		30 Jun 2017	30 Jun 2016	30 Jun 2017	30 Jun 2016
		$$'000	$$'000	$$'000	$$'000

1	Revenue	201,470	154,209	413,714	305,740
2	Profit/(loss) before tax	15,684	7,501	31,829	19,747
3	Profit/(loss) for the period	9,920	25,579	21,671	26,649
4	Profit/(loss) attributable to ordinary equity holders of the parent	6,414	23,959	14,641	23,709
5	Basic earnings/(loss) per share (Subunit)	1.41	5.27	3.22	5.22
6	Proposed/Declared dividend per share (Subunit)	0.00	2.50	2.50	2.50
		AS AT END OF CURRENT QUARTER		AS AT PRECEDING FINANCIAL YEAR END
7	Net assets per share attributable to ordinary equity holders of the parent ($$)	1.6300		1.6300

icy97

Type	Announcement
Subject	OTHERS
Description	CHEMICAL COMPANY OF MALAYSIA BERHAD (CCM OR COMPANY)PROPOSED ACQUISITION  OF:(I)        10% EQUITY INTEREST IN CCM CHEMICALS SDN BHD (CCM CHEMICALS) FROM LANJUT SETIA SDN BHD (LSSB) (PROPOSED ACQUISITION 1); AND(II)        10% EQUITY INTEREST IN CCM CHEMICALS FROM PERMODALAN NASIONAL BERHAD (PNB) (PROPOSED ACQUISITION 2)(COLLECTIVELY REFERRED TO AS THE PROPOSED ACQUISITIONS)
The Board of Directors (“Board”) of CCM is pleased to announce that on 10 August 2017, CCM received a letter of offer from LSSB to dispose 2,000,000 ordinary shares representing 10% equity interest in CCM Chemicals to CCM (“LSSB Offer Letter”). CCM had on 25 August 2017 accepted the offer from LSSB to acquire 2,000,000 ordinary shares representing 10% equity interest in CCM Chemicals. In conjunction with the Proposed Acquisition 1, CCM had on 15 August 2017 made an offer to acquire 2,000,000 ordinary shares representing 10% equity interest in CCM Chemicals from PNB. CCM had on 24 August 2017 received an acceptance of CCM’s offer from PNB for the acquisition of 2,000,000 ordinary shares representing 10% equity interest in CCM Chemicals (“PNB Acceptance Letter”). Further announcement on the Proposed Acquisitions will be made upon signing of the relevant share sale agreements. The full details of the announcement is per the attached fille. This announcement is dated 25 August 2017.

http://www.bursamalaysia.com/market/listed-companies/company-announcements/5527341

Attachments Minority - Announcement on Proposed Acquisitions (clean).docx

icy97

马化工偕两方购CCM余股

2017年9月21日
（吉隆坡20日讯）马化工（CCM，2879，主板工业产品股）分别与LANJUT SETIA私人有限公司（简称LSSB）和国民投资机构（PNB）签约，各以2000万令吉，收购CCM化学私人有限公司的10%股权。

马化工昨天向交易所报备，周二共签署了两项合约。第一份合约是以2000万令吉，向LSSB收购CCM化学的10%。

而第二份合约，则是同样以2000万令吉，向PNB收购CCM化学的10%股权。

目前，马化工是通过子公司CCM Usaha Kimia（大马）私人有限公司，持有CCM化学的80%股权。

这也意味着，增持20%股权后，马化工将全面持有CCM化学。

根据文告，CCM化学的主要业务是制造与营销氯碱及凝血剂产品。同时，也有经销工业与特殊化学品。

马化工表示，收购资金将从早前建议的私下配售活动中筹得。

在过去几年，马化工一直持续检视公司组合，并强化资产负债表。

该公司决定进一步强化现有的化学业务，并巩固其在该领域的地位，以符合持续削减负债、改善负债、刺激独立业务增长的策略。

虽然市场竞争激烈，但CCM化学预计能持续交出正面表现。

该公司也相信，这项收购可以贡献未来净利，整项活动预计可在年杪完成。【e南洋】

Type	Announcement
Subject	OTHERS
Description	PROPOSED ACQUISITIONS OF:(I)        10% EQUITY INTEREST IN CCM CHEMICALS SDN BHD ("CCM CHEMICALS") FROM LANJUT SETIA SDN BHD ("LSSB") (PROPOSED ACQUISITION 1); AND(II)        10% EQUITY INTEREST IN CCM CHEMICALS FROM PERMODALAN NASIONAL BERHAD ("PNB") (PROPOSED ACQUISITION 2)(COLLECTIVELY REFERRED TO AS THE PROPOSED ACQUISITIONS)
The Board of Directors (“Board”) of the Company (“CCM”) is pleased to announce that CCM had, on 19 September 2017, entered into a Sale of Shares Agreement with LSSB (“SSA 1”) and a Sale of Shares Agreement with PNB ("SSA 2"), in relation to the Proposed Acquisitions. CCM intends to undertake the Proposed Acquisitions to further consolidate its existing Chemicals Division and strengthen its position in the chemicals industry, wherein upon completion of the Proposed Acquisitions, CCM Chemicals will effectively be a wholly owned subsidiary of the Company. Details of the announcement on the Proposed Acquisitions are as per attached.

http://www.bursamalaysia.com/market/listed-companies/company-announcements/5548013

Attachments ANN - Minority SSA (clean)_v2 (1)(NAS).docx

icy97

售非核心资产有助减债．马化学分拆业务仍有利可图

（吉隆坡3日讯）马化学（CCM，2879，主板工业产品组）在完成份拆业务后，有信心剩下的化学及聚合物涂料业务依然可为股东带来利益，且在脱售非核心资产下，有望在明年杪降低负债比至0.7倍。

马化学董事经理李奥纳阿里夫在股东特大后表示，该公司把马化学药业（CCMDBIO，7148，主板消费品组）分拆后，马化学将专注在化学及聚合物涂料业务，后者则专注于药剂业务。

他补充，马化学目前有供应污水处理及胶手套所需的化学产品，而未来3至5年潜在参与的则有冷岳污水处理站2项目。

李奥纳阿里夫表示，分拆业务后，马化学的资本开支将能专注于拓展保留的业务。

他相信，在分拆活动完成后，股东将陆续看到马化学的价值。

药剂业务仅贡献盈利50%

“股东们以为马化学分拆了获利较高的业务，其实不然，根据2017上半年业绩表现，尽管药剂业务贡献了约60%营业额，但是，盈利贡献也仅有50%。”

马化学截至2017年上半年，药剂业录得务逾2亿4035万5000令吉营业额，化学及聚合物涂料业务录得的营业额则有1亿6989万7000令吉；净利方面，药剂业务贡献1920万5000令吉，化学及聚合物涂料业务贡献1亿9311万令吉。

他也指出，马化学向两名股东收购CCM化学公司余下20%股权，在完成后，CCM化学公司将成为马化学独资子公司，意味马化学已独立各拥有化学及聚合物涂料业务公司。

负债比有望降至0.7倍

李奥纳阿里夫也指出，在完成份拆计划后，马化学的负债比将上涨至1.51倍，不过，随公司脱售资产，有望在明年杪，将负债比降低至0.7倍。

马化学目前在进行脱售沙亚南土地计划，并预计将陆续脱售位于汝来的土地及持有的韩国上市公司──Pan Gen股权。

针对私下配售计划进展，李奥纳阿里夫直言，公司希望能够尽快完成私下配售计划。

他指出，国民投资公司（PNB）是该公司物色的其中一家潜在认购股权的公司。

进行路演

另外，该公司也进行路演，与超过14个来自大马及新加坡的投资机构及投资者接触。

李奥纳阿里夫表示，在完成份拆后，马化学将变成小资本公司，因此，物色的都是小资本投资者。

国民投资公司一旦认购全数10%私下配售股权，在马化学的持股将增加至72.96%，而持有马化学药业的股权也将额外增加6.67%。

反之，如果国民投资公司没有认购任何股权，握有马化学的股权将稀释至63.87%，且仅持有马化学药业46.86%股权。

李奥纳阿里夫认为，在马化学分发马化学药业股权予股东后，对股东而言更有利，因为握有两家公司股权比握有一家整合公司股权更有价值。

“三合一”整合股票

马化学将以“三合一”比例进行股票整合，在整合后，每持有1股马化学股权者，将获得1.29股马化学药业股权。

李奥纳阿里夫指出，马化学及马化学药业的业务结构在分拆后，并不会出现变化。

“董事部结构及是否会更换名字，则需透过董事会议作出评估才有结果。”

也是马化学药业首席执行员的李奥纳阿里夫表示，董事部分开监管是一个好的事情。

马化学于今日举行的特大上，包括私下配售、分拆业务、整合股票及派发股权的建议，获得99.99%股东支持通过。

文章来源：
星洲日报‧财经‧2017.10.04

icy97

CHEMICAL COMPANY OF MALAYSIA BERHAD

1. Details of Corporate Proposal
Involve issuance of new type/class of securities ?	No
Types of corporate proposal	Private Placement
Details of corporate proposal	Placement of 45,463,186 new ordinary shares in Chemical Company of Malaysia Berhad ("CCMB"), representing 10% of the issued share capital of CCMB (excluding treasury shares)
No. of shares issued under this corporate proposal	45,463,186
Issue price per share ($$)	Malaysian Ringgit (MYR)   1.3200
Par Value($$) (if applicable)
Latest issued share capital after the above corporate proposal in the following
Units	503,093,042
Issued Share Capital ($$)	Malaysian Ringgit (MYR) 557,584,208.620
Listing Date	13 Oct 2017

icy97

馬化工第3季轉盈

2017年11月24日
（吉隆坡24日訊）化學與聚合物業提高收入，馬化工（CCM，2879，主要板工業）截至9月底2017財年第3季轉盈，淨賺820萬令吉。

馬化工向馬證交所報備，第3季營業額升16.7%至8812萬令吉。

化學業務營業額增19%至6820萬令吉，主要因更高的銷售、平均售價及賺幅。

聚合物業而言，營業額增6%至2050萬令吉，歸功于產品組合和特定產品售價改善。

該公司首9個月淨賺2284萬令吉，淨利比去年同期高出6.5倍；營業額起17.4%，錄得2億6148萬令吉。【中国报财经】

SUMMARY OF KEY FINANCIAL INFORMATION 30 Sep 2017

		INDIVIDUAL PERIOD		CUMULATIVE PERIOD
		CURRENT YEAR QUARTER	PRECEDING YEAR CORRESPONDING QUARTER	CURRENT YEAR TO DATE	PRECEDING YEAR CORRESPONDING PERIOD
		30 Sep 2017	30 Sep 2016	30 Sep 2017	30 Sep 2016
		$$'000	$$'000	$$'000	$$'000

1	Revenue	88,118	75,506	261,477	222,641
2	Profit/(loss) before tax	835	1,385	7,900	3,468
3	Profit/(loss) for the period	11,594	-23,506	33,265	3,143
4	Profit/(loss) attributable to ordinary equity holders of the parent	8,199	-20,652	22,839	3,057
5	Basic earnings/(loss) per share (Subunit)	1.80	-4.54	5.02	0.67
6	Proposed/Declared dividend per share (Subunit)	0.00	2.50	2.50	5.00
		AS AT END OF CURRENT QUARTER		AS AT PRECEDING FINANCIAL YEAR END
7	Net assets per share attributable to ordinary equity holders of the parent ($$)	1.6500		1.6300

icy97

icy97 发表于 20-9-2017 03:41 AM
马化工偕两方购CCM余股

2017年9月21日
（吉隆坡20日讯）马化工（CCM，2879，主板工业产品股）分别与LANJUT SETIA私人有限公司（简称LSSB）和国民投资机构（PNB）签约，各以2000万令吉，收购CCM化学私人有限公司 ...

Type	Announcement
Subject	OTHERS
Description	CHEMICAL COMPANY OF MALAYSIA BERHAD ("CCM" OR "THE COMPANY")PROPOSED ACQUISITION OF:(I)        10% EQUITY INTEREST IN CCM CHEMICALS SDN BHD ("CCM CHEMICALS") FROM LANJUT SETIA SDN BHD ("LSSB") (PROPOSED ACQUISITION 1); AND(II)        10% EQUITY INTEREST IN CCM CHEMICALS FROM PERMODALAN NASIONAL BERHAD ("PNB") (PROPOSED ACQUISITION 2)(COLLECTIVELY REFERRED TO AS THE PROPOSED ACQUISITIONS)
The terms used herein shall, unless the context otherwise stated, bear the same meaning as those defined in the announcements of CCM in relation to the Proposed Acquisitions dated 25 August 2017, 19 September 2017 and 21 September 2017(“Announcements”). Further to the Announcements, the Board of Directors of CCM wishes to announce that the Proposed Acquisitions were completed on 24 November 2017 in accordance with the terms and conditions of the Share Sale Agreements. CCM Chemicals is now a wholly-owned subsidiary of the Company. This announcement is dated 24 November 2017.

icy97

Type	Announcement
Subject	MULTIPLE PROPOSALS
Description	CHEMICAL COMPANY OF MALAYSIA BERHAD ("CCMB" OR THE "COMPANY")(I)             PROPOSED PLACEMENT;  (II)            PROPOSED DISPOSAL OF SHAH ALAM LAND;  (III)           PROPOSED DISTRIBUTION; AND  (IV)           PROPOSED SHARE CONSOLIDATION  (COLLECTIVELY REFERRED TO AS "PROPOSALS")
(Unless otherwise stated, all abbreviations and definitions used herein shall have the same meaning as those used in the Company’s announcement dated 2 August 2017 in relation to the Proposed Disposal of Shah Alam Land) We refer to the Company’s announcements dated 2 August 2017, 4 August 2017, 11 August 2017, 30 August 2017, 19 September 2017 and 31 October 2017 in relation to the Proposed Disposal of Shah Alam Land. On behalf of the Board, Maybank IB wishes to announce that the Company has today entered into a SPA with Global Vision Logistics Sdn Bhd (“GVL” or “Purchaser”), being the party nominated by GBA Corp for purposes of the conditional SPA, for the Proposed Disposal of Shah Alam Land. Please refer to the attachment for further details

http://www.bursamalaysia.com/market/listed-companies/company-announcements/5622417

Attachments CCMB Announcement - Shah Alam Land Disposal execution (final).pdf

icy97

马化工集团董事经理
伦纳德转任马化工药业MD

2017年12月6日
（吉隆坡5日讯）原任马化工（CCM，2879，主板工业产品股）集团董事经理伦纳德阿立夫，将担任马化工药业（CCMDBIO，7148，主板消费产品股）的董事经理。

马化工昨天向马交所报备，较早前今年8月时，公司宣布将旗下马化工药业分拆出来的计划，预计可在今年底前完成，而之后伦纳德将会成为马化工药业的董事经理。

根据文告，现任马化工营运总监兼财务总监的妮法兹拉，将会接任伦纳德成为集团董事经理。

另外，马化工药业现任主席拿督哈佳诺玛拉将会卸任，而独立非执行丹斯里西蒂萨蒂亚，将会被委任为公司的非独立非执行主席。【e南洋】

Type	Announcement
Subject	OTHERS
Description	Chemical Company of Malaysia Berhad Appoints New Group Managing Director
We attach herewith a copy of the press release on the above dated 4 December 2017. This announcement is dated 4 December 2017.

http://www.bursamalaysia.com/market/listed-companies/company-announcements/5625257

Attachments Press Release - CCMB Appoints New GMD (1).docx

icy97

EX-date	20 Dec 2017
Entitlement date	22 Dec 2017
Entitlement time	05:00 PM
Entitlement subject	Share Consolidation
Entitlement description	Share consolidation involving the consolidation of every 3 existing ordinary shares in Chemical Company of Malaysia Berhad ("CCMB" or "Company") into 1 ordinary share in CCMB ("CCMB Consolidated Share(s)") ("Share Consolidation")
Period of interest payment	to
Financial Year End	31 Dec 2018
Share transfer book & register of members will be	to   closed from (both dates inclusive) for the purpose of determining the entitlement
Registrar or Service Provider name, address, telephone no	SYMPHONY SHARE REGISTRARS SDN BHDLevel 6, Symphony HouseBlock D 13, Pusat Dagangan Dana 1Jalan PJU 1A/4647301 Petaling JayaSelangorTel no.: 03 7841 8000Fax no.: 03 7841 8008
Payment date
a.Securities transferred into the Depositor's Securities Account before 4:00 pm in respect of transfers	22 Dec 2017
b.Securities deposited into the Depositor's Securities Account before 12:30 pm in respect of securities exempted from mandatory deposit	20 Dec 2017
c. Securities bought on the Exchange on a cum entitlement basis according to the Rules of the Exchange.
Number of new shares/securities issued (units) (If applicable)
Entitlement indicator	Ratio
Ratio	3 : 1

icy97

EX-date	20 Dec 2017
Entitlement date	22 Dec 2017
Entitlement time	05:00 PM
Entitlement subject	Others
Entitlement description	Distribution of 204,665,784 ordinary shares in CCM Duopharma Biotech Berhad ("CCMD") ("Distribution Shares"), being the entire shareholding of Chemical Company of Malaysia Berhad ("CCMB" or "Company") in CCMD, to the entitled shareholders of CCMB by way of reducing its share capital by RM475,736,645.70, effected via special resolution and confirmation by the High Court of Malaya pursuant to Sections 115(a) and 116 of the Companies Act, 2016 ("Distribution")
Period of interest payment	to
Financial Year End	31 Dec 2017
Share transfer book & register of members will be	to   closed from (both dates inclusive) for the purpose of determining the entitlement
Registrar or Service Provider name, address, telephone no	TRICOR INVESTOR & ISSUING HOUSE SERVICES SDN BHDUnit 32-01, Level 32, Tower AVertical Business Suite, Avenue 3, Bangsar SouthNo. 8, Jalan Kerinchi59200 Kuala LumpurTel no.: 03 2783 9299Fax no.: 03 2783 9222
Payment date
a.Securities transferred into the Depositor's Securities Account before 4:00 pm in respect of transfers	22 Dec 2017
b.Securities deposited into the Depositor's Securities Account before 12:30 pm in respect of securities exempted from mandatory deposit	20 Dec 2017
c. Securities bought on the Exchange on a cum entitlement basis according to the Rules of the Exchange.
Number of new shares/securities issued (units) (If applicable)
Entitlement indicator	Ratio
Ratio	1.22 : 1

icy97

馬化工子公司 斥2080萬購辦公樓廠房

2017年12月20日
（吉隆坡20日訊）馬化工（CCM，2879，主要板工業）宣布，旗下獨資子公司CCM Polymers私人有限公司看好市場需求增長，斥資2080萬令吉在萬宜新鎮購入雙層辦公樓及廠房。

馬化工向馬證交所報備文告，CCM Polymers已與賣主Space房地產私人有限公司簽署買賣協議，上述收購價格較市值1950萬令吉高出130萬令吉，並由一名獨立的專業估價師進行評估。

文告指出，上述房產建在一塊7969平方公尺擁99年地契土地上，上面建有一棟雙層辦公樓及廠房以及一棟單層的附屬廠房。

馬化工透過文告指出，根據橡膠手套行業的增長預期，收購上述房產將提供其足夠空間來運作和優化發展空間，並實現滿足不斷增長的市場需求的機會。

另外，收購上述房產也讓馬化工得以為聚合物（Polymer）業務的營運提供足夠的空間，供更好的生產流程和化學處理程序，這與未來業務擴張及成長方向目標一致。

馬化工表示將通過對外借貸和內部措資各一半來完成上述支付。【中国报财经】

Type	Announcement
Subject	OTHERS
Description	SALES AND PURCHASE AGREEMENT BETWEEN CCM POLYMERS SDN BHD  AND SPACE PROPERTIES SDN BHD
The Board of Directors of Chemical Company of Malaysia Berhad (“CCM” or “the Company”) wishes to announce that CCM Polymers Sdn Bhd (hereinafter referred to as “CCM Polymers” or "the Purchaser”), a wholly-owned subsidiary of the Company, has on 19 December 2017 entered into a Sale and Purchase Agreement (hereinafter referred to as “the Agreement”) with Space Properties Sdn Bhd (hereinafter referred to as "the Vendor”) for the purchase of all that piece of leasehold land held under HS(D) 52916, PT 41065 District Ulu Langat, Bandar Baru Bangi, District of Ulu Langat, State of Selangor (hereinafter referred to as "the Land") measuring 7,969 m2 together with a double storey office cum factory and an annexed single storey factory erected thereon, having a postal address at No. 69, Jalan P10/21, Taman Industri Selaman, Seksyen 10, 43650  Bandar Baru Bangi, Selangor Darul Ehsan and the fixtures and fittings  ( hereinafter referred to as the "Fixtures and Fittings") therein (the Land, the Building and the Fixtures and Fittings are collectively referred to as "the Property) at a purchase price of RM20.8 million (exclusive of Goods and Services Tax (“GST”) , stamp duty and legal fees) and upon the terms and conditions therein contained. The purchase of the Property is necessary to provide sufficient space for the Company's Polymers' business operation as well as, to provide optimal room for development and realize opportunities to meet the growing market demands. The details of the announcement is as per attached. This announcement is dated 19 December 2017.

http://www.bursamalaysia.com/market/listed-companies/company-announcements/5642089

Attachments ANN - Polymers Lot 69 (Final) (1).doc

icy97

Type	Reply to Query
Reply to Bursa Malaysia's Query Letter - Reference ID	IQL-20122017-00001
Subject	SALES AND PURCHASE AGREEMENT BETWEEN CCM POLYMERS SDN BHD AND SPACE PROPERTIES SDN BHD
Description	We refer to our announcement dated 19 December 2017 and Bursa Malaysia query on the above and are pleased to provide additional information in relation to the Sales and Purchase Agreement entered into by our wholly owned subsidiary, CCM Polymers Sdn Bhd and Space Properties Sdn Bhd.The details are as per the attached file.
Query Letter Contents	We refer to your Company’s announcement dated 19 December 2017, in respect of the aforesaid matter. In this connection, kindly furnish Bursa Securities with the following additional information for public release:- 1)      Further information on the Property as required under Paragraph 1, Part C of Appendix 10A of the Main Market Listing Requirements (“LR”). 2)      Further justification for the Purchase Price to be at a premium to the market value of the Property as appraised by Messrs. Mohd Noor & Partners. 3)      Method of valuation adopted by Messrs. Mohd Noor & Partners in valuing the Property. 4)      The implication arising from the termination of the Agreement, in particular the deposit paid by the Purchaser. 5)      Financial effect on gearing as the 50% of the Purchase Price will be funded through the external borrowings. 6)      Details of the directors, major shareholders of Space Properties Sdn Bhd together with their respective shareholdings. 7)      The highest percentage ratio applicable to the acquisition of the Property pursuant to paragraph 10.02(g) of the LR.
http://www.bursamalaysia.com/market/listed-companies/company-announcements/5644589

Attachments Query Letter from Bursa Final (2).docx

icy97

Date of change	28 Dec 2017
Name	ENCIK LEONARD ARIFF BIN ABDUL SHATAR
Age	53
Gender	Male
Nationality	Malaysia
Designation	Managing Director
Directorate	Executive
Type of change	Resignation
Reason	The completion of the corporate exercise undertaken by the company in respect of the following, as announced to Bursa Malaysia on 2 August 2017, 4 August 2017, 11 August 2017, 30 August 2017, 25 September 2017, 3 October 2017, 13 October 2017, 28 November 2017,  22 December 2017 and  26 December 2017 on:-(i)        Proposed Placement of up to 10% of the Issued Share Capital of CCMB (Excluding Treasury Shares) (Proposed Placement); (ii)        Proposed Distribution of the entire shareholding in CCM Duopharma Biotech Berhad (CCMD) (Proposed Distribution) to the Shareholders of CCMB by way of a reduction of the paid up capital Of CCMB pursuant to Section 116 of the Companies Act 2016 (Proposed Distribution and Capital Reduction); iiiI)        Proposed Share Consolidation of every 3 existing ordinary shares in CCMB ("CCMB Share(s)" Or "Share(s)") into 1 Ordinary Share in CCMB ("Consolidated Share(s)") ("Proposed Share Consolidation").
Details of any disagreement that he/she has with the Board of Directors	No
Whether there are any matters that need to be brought to the attention of shareholders	No
Qualifications	1) LL.B, Monash University, Melbourne, Australia2) Bachelor of Economics, Monash University, Melbourne, Australia
Working experience and occupation	Leonard Ariff was appointed as Group Managing Director of Chemical Company of Malaysia Berhad on 9 January 2015. He is also the Chief Executive Officer of CCM Duopharma Biotech Berhad. Leonard Ariff was also the Director of CCM Chemicals' Division from October 2014 until December 2015. Following the internal reorganisation of the CCM Group in January 2016, Leonard Ariff's position as Director of Pharmaceuticals Division has been redesignated as Chief Executive Officer, Pharmaceuticals.Leonard Ariff started his career in 1988 in various capacities in the legal profession before joining the CCM Group in 1990, where his main responsibilities were in business development and business management at CCM Chemicals Sdn. Bhd. In 2000, he assumed the position of Managing Director of Usaha Pharma (M) Sdn. Bhd. (formerly known as Prima Health Pharmacy (Retail) Sdn. Bhd.), CCM's pharmaceuticals retail arm. He later joined ICI Paints Malaysia Sdn. Bhd. in 2003 as the General Manager and was subsequently appointed as Managing Director in 2005 to 2007, before re-joining the CCM Group in 2008. He holds directorships on the boards of Orica-CCM Energy Systems Sdn Bhd, an associate company of Chemical Company of Malaysia Berhad and PanGen Biotech Inc. (Korea). He also acts in an advisory capacity at  the International Medical University School of Pharmacy, Chair of the School of Business Advisory Board at Monash University Malaysia, Industrial and Community Advisory panel of Institute for Research in Molecular Medicine ("INFORMM") at University Sains Malaysia, and Committee Member of Good Governance for Medicines in the Ministry of Health, Malaysia and is a member of the Malaysian National Biotech Advisory Board.